FM
NWBO

Family Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Family Management’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-105,975
Closed -$58K – 85
2016
Q3 		$58K Buy
105,975
+18,975
+22% +$8.68K 0.03% 76
2016
Q2 		$51K Sell
87,000
-8,000
-8% -$8.54K 0.03% 79
2016
Q1 		$139K Buy
95,000
+5,000
+6% +$9.87K 0.09% 65
2015
Q4 		$288K Sell
90,000
-100,141
-53% -$482K 0.15% 62
2015
Q3 		$1.19M Buy
190,141
+21,070
+12% +$197K 0.52% 50
2015
Q2 		$1.68M Buy
169,071
+86,196
+104% +$755K 0.69% 43
2015
Q1 		$611K Buy
82,875
+16,000
+24% +$108K 0.28% 53
2014
Q4 		$358K Buy
66,875
+1,000
+2% +$5.12K 0.16% 65
2014
Q3 		$331K Buy
65,875
+24,000
+57% +$147K 0.15% 64
2014
Q2 		$281K Buy
41,875
+13,750
+49% +$87.5K 0.14% 66
2014
Q1 		$204K Buy
28,125
+1,545
+6% +$9.16K 0.11% 68
2013
Q4 		$100K Buy
26,580
+14,250
+116% +$55.1K 0.06% 64
2013
Q3 		$41K Hold
12,330
– – 0.03% 64
2013
Q2 		$41K Buy
+12,330
New +$44.7K 0.02% 77

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Family Management's NWBO Position: Q4 2016 in Review

Family Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 105,975 shares — an estimated $58K sold.

Family Management first reported a position in NWBO in Q2 2013 and held it in 14 quarters. The position peaked at $1.68M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Family Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Family Management sold 105,975 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $58K.
  • Family Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 14 quarters.
  • Family Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $1.68M in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Family Management's 13F filing for Q4 2016, filed 10 Feb 2017.